Recently, two randomized controlled trials (RCTs) demonstrated that tirzepatide, a dual GLP-1/GIP receptor agonists, reduced the AHI and hypoxic burden, and improved sleep-related patient-reported outcomes among individuals with moderate-to-severe OSA [24]
[8] The superior BDNF response to paraxanthine may help explain its enhanced cognitive benefits compared to caffeine
The FAERS database is a publicly accessible, voluntary reporting system that compiles safety reports on approved drugs and therapeutic biologics submitted by healthcare professionals, pharmaceutical manufacturers, patients, and others
Is GLP-1 Probiotic Pro safe
As the market continues to evolve, stakeholders must remain vigilant to emerging trends and shifts in consumer preferences, which could significantly influence strategic decisions moving forward
J Clin Psychiatry 2015;76:665